Rejuvel Bio-Sciences, Inc. a NASA Technology Partner, has appointed David Pollock, President of Rejuvel’s joint venture subsidiary Zero Gravity Sciences, Inc. and President of Brand Labs USA, LLC., to its Board of Directors.
Pompano Beach, FL, May 2, 2019 — Rejuvel Bio-Sciences, Inc. (OTC Markets (NUUU), a NASA Technology Partner, has appointed David Pollock, President of Rejuvel’s joint venture subsidiary Zero Gravity Sciences, Inc. and President of Brand Labs USA, LLC., to its Board of Directors.
As one of the top cosmetic formulators with almost three decades of experience, Pollock has developed products for some of the most prestigious names and was named one of the twenty to know in the industry. Pollock is also the founder of Brand Labs USA, LLC. (BLU), a privately held product development laboratory and contract manufacturer of cosmeceutical and other personal care products. BLU’s clients range from television shopping channels to certain direct-to-consumer infomercial and on-line brands to physician and high-end luxury brands. www.BrandLabsUsa.com.
“Rejuvel Bio-Sciences is very excited to have David Pollock on our Board with his vast business experience in development, marketing and manufacturing for the beauty industry,” said Charles Scimeca, CEO of Rejuvel Bio-Sciences stated.
“Working with our exclusive NASA technology, the zero-gravity bio-reactor technology platform opens the door to extremely innovative 3-dimensional molecules for therapeutic topicals and ingestibles that go beyond stem cells and growth factors. We are developing a complete line of technologically advanced products for our Rejuvel brand, as well as some of our clients and prospective client network,” said David Pollock.
As part of arrangement, Rejuvel Bio-Sciences, Inc. has moved its corporate office to the Brand Labs USA/Zero Gravity Sciences manufacturing joint venture facility at 325 SW 15th Avenue Pompano Beach, FL 33069.
Rejuvel is continuing its efforts to become fully reporting. The Company will update their shareholders and the public on current and future developments through press releases.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Rejuvel Bio-Sciences, Inc.
15800 Pines Blvd, Suite 3116
Pembroke Pines, FL 33027